Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi
2 other identifiers
interventional
1,116
1 country
1
Brief Summary
There is promising evidence that couple-based approaches within Malawi's Option B+ prevention of mother to child transmission program could address help address 1) poor male engagement in the HIV continuum of care, 2) low male adoption of biomedical HIV prevention approaches, 3) sub-optimal female engagement in the continuum of care, and 4) poor or uncertain infant outcomes. Our team has developed an intervention to address these challenges, and will conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at one year. Women with recent HIV infections enrolled in this trial will be compared against a cohort of 350 HIV-uninfected women to explore predictors of HIV acquisition in pregnancy in Malawi.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Sep 2017
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2017
CompletedFirst Submitted
Initial submission to the registry
March 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedResults Posted
Study results publicly available
June 24, 2021
CompletedJune 24, 2021
March 1, 2021
2.8 years
March 19, 2018
April 30, 2021
June 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Number of Women Retained in Care
Women who presented at 12 months and reported taking at least one dose of ART in the last seven days
12 months
Number of Women With Viral Suppression
Women who presented at 12 months with a viral load \<1000 copies/mL
12 months
Number of HIV-positive Male Partners Aware of Their HIV-positive Status
HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit
12 months
Number of HIV-positive Male Partners Retained in Care
HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days
12 months
Number of HIV-positive Male Partners With Viral Suppression
HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL
12 months
Number of HIV-negative Men Without HIV Exposure From Their Primary Partner
HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner
12 months
Secondary Outcomes (2)
Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis
12 months
Predictors of Recent HIV Infection
At the day of female consent
Study Arms (3)
Individual (SOC)
NO INTERVENTIONHIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.
Couple (Intervention)
EXPERIMENTALIn addition to receiving standard of care procedures, HIV-infected pregnant women in the couple arm will be provided with an intervention aimed at recruiting their male partners, providing enhanced couple counseling and testing, engaging their male partners in their care, and supporting male partners to receive care and treatment services.
HIV-Uninfected Cohort
NO INTERVENTIONHIV-uninfected pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
Interventions
Participants are provided study-specific partner referral cards and encouraged to bring male partners to antenatal care for a male engagement intervention. Those who do not present on their own are then traced. Couples will receive three enhanced couple counseling sessions that include: pre-test counseling, return of joint results, and post-test counseling. HIV-infected men will be able to initiate cART at the antenatal clinic and the couple will be offered condoms from the HTC counselor. Between sessions, couple members can pick up condoms and cART for one another.
Eligibility Criteria
You may qualify if:
- HIV-infected and eligible for Option B+
- \>18 years old or 15-17 years old and married
- Planning to remain in the Bwaila catchment area for the next year or notify the study team if they leave the area or change facilities
- Part of a heterosexual relationship for \>3 months
- Expects the partner to be in the relevant catchment area for at least one week in the next six months.
- Able and willing to give locator information for this partner
- Willing to have study staff conduct phone and physical tracing of that partner
- Willing to undergo a couple-based intervention with this partner
- Able and willing to provide informed consent
- \>18 years old or 15-17 years old and married
- In a relationship with the female partner for \>3 months
- Willing to undergo a couples-based intervention with their female partner
- Able and willing to provide informed consent
- HIV-uninfected
- \>18 years old or 15-17 years old and married
- +4 more criteria
You may not qualify if:
- Any condition that in the opinion of the study investigator would compromise the ability of the prospective participant to provide informed consent, undergo study procedures safely, or would prevent proper conduct of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bwaila District Hospital Antenatal Unit
Lilongwe, Central District, Malawi
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nora Rosenberg, PhD, MSPH
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Nora E Rosenberg, PhD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2018
First Posted
March 26, 2018
Study Start
September 25, 2017
Primary Completion
July 21, 2020
Study Completion
September 30, 2020
Last Updated
June 24, 2021
Results First Posted
June 24, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share